Genetics of autoinflammation instructs selective IL-1 targeting
- PMID: 37437532
- DOI: 10.1016/j.immuni.2023.06.010
Genetics of autoinflammation instructs selective IL-1 targeting
Abstract
Interleukin-1 (IL-1) is a primary pro-inflammatory cytokine requiring tightly controlled negative regulation. In this issue of Immunity, Wang et al.,1 inspired by an IL-1 receptor missense mutation associated with unleashed IL-1-mediated inflammation, design a new drug to selectively inhibit IL-1.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment on
-
Identification of an IL-1 receptor mutation driving autoinflammation directs IL-1-targeted drug design.Immunity. 2023 Jul 11;56(7):1485-1501.e7. doi: 10.1016/j.immuni.2023.05.014. Epub 2023 Jun 13. Immunity. 2023. PMID: 37315560
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
